Jay M. Edelberg

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Vera Bittner, Michael Szarek, Philip E. Aylward et al. · Journal of the American College of Cardiology · 2020 · 572 citations · Full text

Medicine, Cardiology, Pharmacology +17

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Young Adult Bone Marrow–Derived Endothelial Precursor Cells Restore Aging-Impaired Cardiac Angiogenic Function

Jay M. Edelberg, Lilong Tang, Koichi Hattori et al. · Circulation Research · 2002 · 321 citations

Life Sciences, Cardiology, Cell Biology +17

A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.

Hartmut Weiler-Guettler, Patricia D. Christie, David Beeler et al. · Journal of Clinical Investigation · 1998 · 253 citations · Full text

Medicine, Genetics, Molecular Genetics +17